icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy 		Back grey_arrow_rt.gif
 
 
 
Elafibranor efficacy in primary biliary cholangitis according
to biochemical response criteria in the phase III ELATIVE® trial
 
 
  EASL 2024 June 5-8

0619241

0619242

0619243

0619244

0619245